{"DataElement":{"publicId":"3536327","version":"1","preferredName":"EBER ISH Result","preferredDefinition":"Result of EBER (Epstein-Barr Virus Small RNA) in situ hybridization (ISH) testing.","longName":"3536324v1.0:3536326v1.0","context":"NCIP","contextVersion":"1","DataElementConcept":{"publicId":"3536324","version":"1","preferredName":"Epstein-Barr Virus Small RNA Fluorescence in situ Hybridization Level","preferredDefinition":"A species of Herpetoviridae that is responsible for infectious mononucleosis (glandular fever). Discovered in 1964, this virus has been associated with Burkitt's lymphoma in South African children and with nasopharyngeal carcinoma in Asian populations._RNA Binding is the molecular interaction between an RNA molecule and a macromolecule (usually protein or nucleic acid) for transport, catalysis, localization, or modification of function._Use of a DNA or RNA probe to detect the presence of complementary sequences in chromosomes, cells, or tissues that uses fluorescent tags to detect hybridization_A position on a scale measuring intensity, quality, or amount.  (NCI)","longName":"3536322v1.0:2238473v1.0","context":"NCIP","contextVersion":"1","ObjectClass":{"publicId":"3536322","version":"1","preferredName":"Epstein-Barr Virus RNA Binding Fluorescence in situ Hybridization","preferredDefinition":"A species of Herpetoviridae that is responsible for infectious mononucleosis (glandular fever). Discovered in 1964, this virus has been associated with Burkitt's lymphoma in South African children and with nasopharyngeal carcinoma in Asian populations.:RNA Binding is the molecular interaction between an RNA molecule and a macromolecule (usually protein or nucleic acid) for transport, catalysis, localization, or modification of function.:A type of IN SITU HYBRIDIZATION in which target sequences are stained with fluorescent dye so their location and size can be determined using fluorescence microscopy. This staining is sufficiently distinct that the hybridization signal can be seen both in metaphase spreads and in interphase nuclei.","longName":"C14204:C20737:C17563","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Epstein-Barr Virus","conceptCode":"C14204","definition":"A species of Herpetoviridae that is responsible for infectious mononucleosis (glandular fever). Discovered in 1964, this virus has been associated with Burkitt's lymphoma in South African children and with nasopharyngeal carcinoma in Asian populations.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"RNA Binding","conceptCode":"C20737","definition":"RNA Binding is the molecular interaction between an RNA molecule and a macromolecule (usually protein or nucleic acid) for transport, catalysis, localization, or modification of function.","evsSource":"CTCAE_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Fluorescence In Situ Hybridization","conceptCode":"C17563","definition":"A physical mapping approach that uses fluorescent tags to detect hybridization of probes within metaphase chromosomes or less condensed somatic interphase chromatin. This technique can be used for identification of chromosomal abnormalities and for gene mapping.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"C60C12FE-0A26-1D09-E040-BB89AD434D85","latestVersionIndicator":"Yes","beginDate":"2012-07-30","endDate":null,"createdBy":"REEVESD","dateCreated":"2012-07-30","modifiedBy":"ONEDATA","dateModified":"2012-07-30","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2238473","version":"1","preferredName":"Level","preferredDefinition":"A position on a scale measuring intensity, quality, or amount.  (NCI)","longName":"C25554","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Level","conceptCode":"C25554","definition":"A position on a scale measuring intensity, quality, or amount.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"F9FD4EEB-19AF-0B27-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-06-23","endDate":null,"createdBy":"REEVESD","dateCreated":"2005-06-23","modifiedBy":"ONEDATA","dateModified":"2005-06-23","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008557","version":"1","preferredName":"Lab Results","preferredDefinition":"the results of laboratory tests.","longName":"LAB_RESULTS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B2CFBA7D-D009-7227-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-27","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-27","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"C60C12FE-0A34-1D09-E040-BB89AD434D85","latestVersionIndicator":"Yes","beginDate":"2012-07-30","endDate":null,"createdBy":"REEVESD","dateCreated":"2012-07-30","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"3536326","version":"1","preferredName":"ISH (in situ Hybridization) Staining Method Result","preferredDefinition":"Result of Her-2 Testing for amplification, expressed as not amplified, indeterminate, or amplified._In Situ Hybridization staining is an immunohistochemistry staining procedure which allows the demonstration of specific nucleic acid sequences (genes) in their cellular environment. The DNA sequence in the host cell is detected by hybridization with a biotin-labeled cDNA probe. Used for detecting protein and gene expression, determining tissue specificity, and localizing genes and proteins within tissue samples._The result of an action.","longName":"3536326v1.0","context":"NCIP","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"20","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"Amplified","valueDescription":"Gene Amplification Technique","ValueMeaning":{"publicId":"3534096","version":"1","preferredName":"Gene Amplification Technique","longName":"3534096","preferredDefinition":"This technique refers to selectively replicate DNA sequence of interest to multiple extra copies that meet the need of research or health care activity. Polymerase chain reaction (PCR), can be considered a type of man-made gene amplification process.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Gene Amplification Technique","conceptCode":"C20589","definition":"This technique refers to selectively replicate DNA sequence of interest to multiple extra copies that meet the need of research or health care activity. Polymerase chain reaction (PCR), can be considered a type of man-made gene amplification process.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"C5451973-3422-68B6-E040-BB89AD437DE0","latestVersionIndicator":"Yes","beginDate":"2012-07-20","endDate":null,"createdBy":"REEVESD","dateCreated":"2012-07-20","modifiedBy":"ONEDATA","dateModified":"2012-07-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"C60C12FE-0A8C-1D09-E040-BB89AD434D85","beginDate":"2003-11-18","endDate":null,"createdBy":"REEVESD","dateCreated":"2012-07-30","modifiedBy":"ONEDATA","dateModified":"2012-07-30","deletedIndicator":"No"},{"value":"Indeterminate","valueDescription":"Indeterminate","ValueMeaning":{"publicId":"2577194","version":"1","preferredName":"Indeterminate","longName":"2577194","preferredDefinition":"Cannot distinguish between two or more possible values in the current context.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Indeterminate","conceptCode":"C48658","definition":"Cannot distinguish between two or more possible values in the current context.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-FA97-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2003-11-14","endDate":null,"createdBy":"SBREXT","dateCreated":"2003-11-14","modifiedBy":"COOPERM","dateModified":"2008-09-15","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"C60C12FE-0A97-1D09-E040-BB89AD434D85","beginDate":"2003-11-18","endDate":null,"createdBy":"REEVESD","dateCreated":"2012-07-30","modifiedBy":"ONEDATA","dateModified":"2012-07-30","deletedIndicator":"No"},{"value":"Not Amplified","valueDescription":"NOT AMPLIFIED","ValueMeaning":{"publicId":"2559591","version":"1","preferredName":"NOT AMPLIFIED","longName":"2559591","preferredDefinition":"An operation in which a term denies or inverts the meaning of another term or construction.: Addition of extra material.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Negation","conceptCode":"C25594","definition":"An operation in which a term denies or inverts the meaning of another term or construction.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Amplification","conceptCode":"C25418","definition":"Addition of extra material.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-B5D4-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-02-13","endDate":null,"createdBy":"SBR","dateCreated":"2002-02-13","modifiedBy":"COOPERM","dateModified":"2017-03-30","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"C60C12FE-0AA1-1D09-E040-BB89AD434D85","beginDate":"2003-11-18","endDate":null,"createdBy":"REEVESD","dateCreated":"2012-07-30","modifiedBy":"ONEDATA","dateModified":"2012-07-30","deletedIndicator":"No"},{"value":"Not Done","valueDescription":"No testing done","ValueMeaning":{"publicId":"2957556","version":"1","preferredName":"No testing done","longName":"2957556","preferredDefinition":"Indicates that a test was not performed.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Not Tested","conceptCode":"C101887","definition":"Indicates that a test was not performed.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"772A4FB5-6D06-C581-E040-BB89AD431FF5","latestVersionIndicator":"Yes","beginDate":"2009-10-30","endDate":null,"createdBy":"REEVESD","dateCreated":"2009-10-30","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"C60C12FE-0AAB-1D09-E040-BB89AD434D85","beginDate":"2009-11-27","endDate":null,"createdBy":"REEVESD","dateCreated":"2012-07-30","modifiedBy":"ONEDATA","dateModified":"2012-07-30","deletedIndicator":"No"},{"value":"Unknown","valueDescription":"Unknown","ValueMeaning":{"publicId":"2575365","version":"1","preferredName":"Unknown","longName":"2575365","preferredDefinition":"Not known, not observed, not recorded, or refused.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Unknown","conceptCode":"C17998","definition":"Not known, observed, recorded; or reported as unknown by the data contributor.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-F372-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-06-15","endDate":null,"createdBy":"SBR","dateCreated":"2002-02-13","modifiedBy":"MMADDINENI","dateModified":"2024-01-05","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"C60C12FE-0AB5-1D09-E040-BB89AD434D85","beginDate":"2009-11-27","endDate":null,"createdBy":"REEVESD","dateCreated":"2012-07-30","modifiedBy":"ONEDATA","dateModified":"2012-07-30","deletedIndicator":"No"},{"value":"Negative","valueDescription":"Negative Finding","ValueMeaning":{"publicId":"2617835","version":"1","preferredName":"Negative Finding","longName":"2617835","preferredDefinition":"A finding of normality following an examination or investigation looking for the presence of a microorganism, disease, or condition.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Negative Finding","conceptCode":"C38757","definition":"A finding of normality following an examination or investigation looking for the presence of a microorganism, disease, or condition.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"2CAF63D8-1F72-70DF-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-03-27","endDate":null,"createdBy":"CURTIST","dateCreated":"2007-03-27","modifiedBy":"DWARZEL","dateModified":"2022-10-03","changeDescription":"Updated VM Short Name to be the Public ID to be consistent with current convention for VM Short Name - DW 10-03-2022","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"4BF89437-DD95-14CF-E053-F662850AAC82","beginDate":"2017-03-30","endDate":null,"createdBy":"COOPERM","dateCreated":"2017-03-30","modifiedBy":"ONEDATA","dateModified":"2017-03-30","deletedIndicator":"No"},{"value":"Positive","valueDescription":"Positive Finding","ValueMeaning":{"publicId":"2581523","version":"1","preferredName":"Positive Finding","longName":"2581523","preferredDefinition":"A finding of abnormality following an examination or observation confirming something, such as the presence of a disease, condition, or microorganism.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Positive Finding","conceptCode":"C38758","definition":"A finding of abnormality following an examination or observation confirming something, such as the presence of a disease, condition, or microorganism.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE88-0B80-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-10-31","endDate":null,"createdBy":"UMLLOADER_CAE","dateCreated":"2006-10-31","modifiedBy":"CLOHNES","dateModified":"2023-11-09","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"4BF89437-DD9F-14CF-E053-F662850AAC82","beginDate":"2017-03-30","endDate":null,"createdBy":"COOPERM","dateCreated":"2017-03-30","modifiedBy":"ONEDATA","dateModified":"2017-03-30","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008557","version":"1","preferredName":"Lab Results","preferredDefinition":"the results of laboratory tests.","longName":"LAB_RESULTS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B2CFBA7D-D009-7227-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-27","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-27","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"3536325","version":"1","preferredName":"in situ Hybridization Staining Method Outcome","preferredDefinition":"In Situ Hybridization staining is an immunohistochemistry staining procedure which allows the demonstration of specific nucleic acid sequences (genes) in their cellular environment. The DNA sequence in the host cell is detected by hybridization with a biotin-labeled cDNA probe. Used for detecting protein and gene expression, determining tissue specificity, and localizing genes and proteins within tissue samples.:The result of an action.","longName":"C23022:C20200","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"In Situ Hybridization Staining Method","conceptCode":"C23022","definition":"A staining procedure which detects and indicates the location of specific nucleic acid sequences in a tissue or cellular sample. The DNA or RNA sequence of interest in the host cell is detected by hybridization with a labeled cDNA, RNA or modified nucleic acid-containing probe.","evsSource":"RADLEX_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Outcome","conceptCode":"C20200","definition":"The result of an action.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"C60C12FE-0A66-1D09-E040-BB89AD434D85","latestVersionIndicator":"Yes","beginDate":"2012-07-30","endDate":null,"createdBy":"REEVESD","dateCreated":"2012-07-30","modifiedBy":"ONEDATA","dateModified":"2012-07-30","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"C60C12FE-0A77-1D09-E040-BB89AD434D85","latestVersionIndicator":"Yes","beginDate":"2012-07-30","endDate":null,"createdBy":"REEVESD","dateCreated":"2012-07-30","modifiedBy":"COOPERM","dateModified":"2017-03-30","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"5655968","version":"1","longName":"HTMCP (HIV+Tumor Molecular Characterization Project)","context":"OCG","ClassificationSchemeItems":[{"publicId":"10000067","version":"1","longName":"HTMCP","context":"OCG"}]}],"AlternateNames":[{"name":"EBER_ISH_RES","type":"Synonym","context":"NCIP"},{"name":"OCG","type":"USED_BY","context":"OCG"}],"ReferenceDocuments":[{"name":"EBER ISH Result","type":"Preferred Question Text","description":"EBER ISH Result","url":null,"context":"NCIP"}],"origin":"HTMCP:HIV+ Tumor Molecular Characterization Project","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"C60C12FE-0AC4-1D09-E040-BB89AD434D85","latestVersionIndicator":"Yes","beginDate":"2012-07-30","endDate":null,"createdBy":"REEVESD","dateCreated":"2012-07-30","modifiedBy":"TSESU","dateModified":"2017-02-08","changeDescription":"Curated for HTMCP Initiative","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}